Regeneron Pharmaceuticals says it will acquire 23andMe's assets, including its Personal Genome Service, for $256M, set to close in Q3, in the bankruptcy auction (Dean Seal/Wall Street Journal)
https://www.techmeme.com/feed.xmlHits: 4
Summary
— Welcome again! Earlier, we looked at how personality assessments are evaluation tools that help look at candidates beyond resumes. Let's look at how to use …